PDGFRA公司
癌症研究
医学
靶向治疗
突变体
突变
内科学
生物
癌症
基因
主旨
遗传学
间质细胞
作者
Erica Evans,Alexandra K. Gardino,Joseph L. Kim,Brian L. Hodous,Adam Shutes,Alison Davis,Xing Julia Zhu,Oleg Schmidt-Kittler,Doug Wilson,Kevin Wilson,Lucian DiPietro,Yulian Zhang,Natasja Brooijmans,Timothy P. LaBranche,Agnieszka Woźniak,Yemarshet K. Gebreyohannes,Patrick Schöffski,Michael C. Heinrich,Daniel J. DeAngelo,Steven P. Miller
标识
DOI:10.1126/scitranslmed.aao1690
摘要
BLU-285 is a selective and potent mutant KIT and PDGFRA inhibitor active in both preclinical and clinical settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI